Toth Financial Advisory’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-100
Closed -$4K 779
2021
Q2
$4K Buy
+100
New +$3.89K ﹤0.01% 526
2020
Q2
Sell
-211
Closed -$7K 583
2020
Q1
$7K Buy
+211
New +$7.19K ﹤0.01% 305

Other funds holding PFE

Toth Financial Advisory's PFE Position: Q2 2026 in Review

Toth Financial Advisory reduced its Pfizer (PFE) stake by 16% in Q2 2026, selling an estimated $20.6K and leaving 4,200 shares worth $101K. The position accounts for 0.01% of the portfolio, ranked #296.

Toth Financial Advisory first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $259K in Q4 2021. 1,312 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Toth Financial Advisory held 4,200 shares of Pfizer worth $101K as of Q2 2026.
  • Toth Financial Advisory sold 788 Pfizer shares in Q2 2026, an estimated $20.6K.
  • Pfizer made up 0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #296 holding.
  • Toth Financial Advisory first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
  • Toth Financial Advisory's Pfizer position peaked at $259K in Q4 2021.
  • 1,312 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.